| | | |

HITHOC Treatment Deemed Safe for Some Pleural Mesothelioma Patients

ByAlex Strauss
HITHOC treatment for pleural mesothelioma

German doctors testing the HITHOC treatment for pleural mesothelioma say it is a “safe therapeutic option”. The key to success is careful patient selection.

Pleural mesothelioma is a rare cancer linked to asbestos. Tumors grow on the membrane that surrounds the lungs. Doctors have not yet found a cure for mesothelioma. 

HITHOC treatment involves rinsing heated chemotherapy drugs through the chest after mesothelioma surgery. The new study suggests that this advanced approach may help certain mesothelioma patients live longer. 

Understanding Pleural Mesothelioma Tumors

To understand how HITHOC treatment works, it is important to understand how and where mesothelioma tumors grow. 

Pleural mesothelioma tumors start on the lining around the lungs called the pleura. As tumors grow, the pleura thickens and becomes less pliable. This can make it difficult for patients to take a deep breath. Eventually, cancer cells can spread from the pleura to the lungs and other organs.

The irregular shape and location of pleural tumors makes mesothelioma surgery challenging. Even when the surgeon is as thorough as possible, it is common for some cancer cells to be left behind in the chest. These cancer cells can “seed” new tumors.

HITHOC treatment attempts to kill residual mesothelioma cells. The heated liquid can get into areas of the chest cavity that the surgeon cannot reach or even see. The goal is to keep pleural mesothelioma from coming back. 

HITHOC Treatment Works Better in Some Patients Than Others

The German study included 71 pleural mesothelioma patients who had surgery between 2009 and 2013. The median patient age was 70, which is about average for pleural mesothelioma diagnosis. In all cases, the patients’ tumors were confined to one area of the chest. 

Surgeons removed the diseased pleural lining and as much cancerous tissue as they could see. Patients then got HITHOC treatment with a combination of cisplatin and doxorubicin. 

Some patients lived much longer than others after HITHOC treatment. Those who had epithelioid mesothelioma, the most common subtype, lived for a median of 17.9 months. But patients with the rarer sarcomatoid subtype had a poor median survival of just 9.2 months. 

Not surprisingly, patients whose surgeries were the most complete had much better survival than those where some of the tumor could not be removed. After complete resection and HITHOC treatment, median survival was 28.2 months. Incomplete resection resulted in a median survival of just 13.1 months. 

Lead study author Laura Klotz of the University of Munich concludes that HITHOC treatment is a “safe therapeutic option” for epithelioid mesothelioma patients. It is most likely to be effective in patients with tumors confined to one area. 

Source:

Klotz, LV, et al, “Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma”, May 2019, Journal of Thoracic Disease, pp. 1963- 1972, http://jtd.amegroups.com/article/view/28750/21248

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    ByAlex Strauss

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…